You are here: Home: PCU 1 | 2007: Nicholas J Vogelzang, MD: Select publications

Select Publications

Hussain M et al. Absolute prostate-specific antigen value after androgen deprivation is a
strong independent predictor of survival in new metastatic prostate cancer: Data from Southwest Oncology Group Trial 9346 (INT-0162). J Clin Oncol 2006;24(24):3984-90. Abstract

Prostate Cancer Trialists’ Collaborative Group (PCTCG). Maximum androgen blockade in advanced prostate cancer: An overview of the randomised trials. Lancet 2000;355(9214):1491-8. Abstract

Schmitt B et al. Combined androgen blockade with nonsteroidal antiandrogens for advanced prostate cancer: A systematic review. Urology 2001;57(4):727-32. Abstract

Usami M et al. Bicalutamide 80 mg combined with a luteinizing hormone-releasing hormone agonist (LHRH-A) versus LHRH-A monotherapy in advanced prostate cancer: Findings from a phase III randomized, double-blind, multicenter trial in Japanese patients. Prostate Cancer Prostatic Dis 2007;[Epub ahead of print]. Abstract



PCU Think Tank

Home

Table of Contents

Editor
Neil Love, MD

INTERVIEWS

Eric A Klein, MD
- Select publications

Anthony V D’Amico, MD, PhD
- Select publications

Nicholas J Vogelzang, MD
- Select publications

CME Information

Faculty Disclosures

Editor's Office

 
Terms of Use and General Disclaimer
Copyright © 2007 Research To Practice. All Rights Reserved.